AECOM
For the period ended Sep 30, 2025. Filed Nov 19, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Nov 19, 2025
ACM$70.63+0.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 9B. OTHER INFORMATION
During the quarterly period ended September 30, 2025, no director or officer of the Company adopted orterminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement as each term is defined in Item 408(a) of Regulation S-K, except as follows:
| Name and Title | Date of Adoption ofRule 10b5-1 Trading Plan | Scheduled ExpirationDate of Rule 10b5-1Trading Plan | Aggregate Number ofSecurities to BePurchased or Sold |
|---|---|---|---|
| Lara Poloni, President | 9/11/2025 | 12/31/2025 | Sale of (i) the number of shares of common stock resulting from the vesting of 10,040 restricted stock awards and accrued dividend equivalents and (ii) the number of shares of common stock resulting from the vesting of Performance Earning Program awards (15,060 shares of common stock at target performance) and accrued dividend equivalents |
| David Gan,Chief Legal Officer | 8/14/2025 | 02/09/2026 | Sale of (i) 6,000 shares of common stock, (ii) the number of shares of common stock resulting from the vesting of 5,976 restricted stock awards and accrued dividend equivalents and (iii) the number of shares of common stock resulting from the vesting of Performance Earning Program awards (8,964 shares of common stock at target performance) and accrued dividend equivalents |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.